Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Xuanzhu Biopharmaceutical Co., Ltd.

Clinical trials sponsored by Xuanzhu Biopharmaceutical Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New drug safety check: how does anaprazole affect liver, kidney, and elderly patients? Results expected Oct 2026 (estimated)
  • New acid reducer shows promise in fighting stomach bug Results expected Feb 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1 Not yet recruiting 3
Sort by
  • New acid reflux pill aims to heal esophagus faster

    Symptom relief Recruiting now

    This study tests a new medicine called anaprazole to see if it heals the esophagus better than a standard treatment (rabeprazole) in people with reflux esophagitis. About 500 adults with moderate to severe esophagus damage will take either anaprazole or rabeprazole daily for up t…

    Phase 3 • Sponsor: Xuanzhu Biopharmaceutical Co., Ltd. • Aim: Symptom relief

    Last updated Jun 27, 2026 07:52 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space